Hjem › Tyktarmskræft › Florida
Tyktarmskræft kliniske forsøg i Florida
29 studier for Tyktarmskræft søger deltagere på steder i Florida.
Byer i Florida
- Tampa13 studier
- Jacksonville9 studier
- Miami6 studier
- Sarasota6 studier
- Orlando6 studier
- Gainesville5 studier
- Hollywood4 studier
- Cape Coral3 studier
- Deltona3 studier
- Fort Lauderdale3 studier
- St. Petersburg3 studier
Officiel studietekst (engelsk)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Holy Cross Hospital, Fort Lauderdale
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07283939Family Communications After Genetic Testing
- Holy Cross Hospital, Fort Lauderdale
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Florida Cancer Specialists - South ( Site 7002), Fort Myers
- Mayo Clinic in Florida ( Site 0092), Jacksonville
- Orlando Health Cancer Institute ( Site 0065), Orlando
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06997497A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 7, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07085091Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Florida Cancer Specialists, Bonita Springs
- Florida Cancer Specialists, Bradenton
- Comprehensive Hematology Oncology, Brandon
- og 19 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center and Research Institute, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
- Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT07629960A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Florida Oncology & Hematology, Fort Myers
- University of Florida Health, Gainesville
- Sylvester Comprehensive Cancer Center, Miami
- og 4 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Memorial Healthcare System, Hollywood
- The Oncology Institute of Hope & Innovation, Lakeland
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- University of Florida, Gainesville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07058012Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Bay Pines VA Healthcare System, Bay Pines
- Malcom Randall Veterans Administration Medical Center, Gainesville
- og 8 flere
Rekrutterer
Alder 45 til 70 · Alle køn · Opdateret 2. sep. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- AdventHealth Altamonte, Altamonte Springs
- AdventHealth Celebration, Celebration
- Morton Plant Hospital, Clearwater
- og 21 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT05174169A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Mayo Clinic Florida, Jacksonville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT07321106Shield Post-Approval Study Protocol
- Gastroenterology Consultants of Boca Raton, LLC, Boca Raton
- Manuel Espinel MD PA, Delray Beach
- Innova Pharma Research, LLC, Doral
- og 5 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 45 til 81 · Alle køn · Opdateret 7. aug. 2026 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Jacksonville
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. aug. 2026 · NCT05433142A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 29. jun. 2026 · NCT07458347Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- og 2 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
- Tampa General Hospital, Tampa
Rekrutterer
18 Months – 40 Months · Kvinder · Opdateret 24. jun. 2026 · NCT07419490A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 12. jun. 2026 · NCT06051695A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Orlando
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. jun. 2026 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Florida Cancer Specialists, Sarasota
- Lee Moffitt Cancer Center, Tampa
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 3. jun. 2026 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Memorial Healthcare System, Hollywood
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 27. maj 2026 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. maj 2026 · NCT05379985A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 til 100 · Alle køn · Opdateret 8. maj 2026 · NCT05655494Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT06239194Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- AdventHealth, Orlando
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 7. jan. 2026 · NCT05773144SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2025 · NCT06682793Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
- AdventHealth, Orlando
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 3. jul. 2025 · NCT05789433Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.